Automated Cell Cultures Market Report 2026

The automated cell cultures market size has grown rapidly in recent years. It will grow from $7.02 billion in 2025 to $7.78 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increasing biopharmaceutical research activity, rising demand for standardized cell culture processes, expansion of drug discovery programs, availability of modular automation solutions, growth in academic life science research.

The automated cell cultures market size is expected to see rapid growth in the next few years. It will grow to $11.58 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing investments in cell and gene therapy manufacturing, rising demand for high-throughput screening, expansion of personalized medicine research, growing adoption of automation in laboratories, increasing focus on scalable biologics production. Major trends in the forecast period include increasing deployment of fully automated cell culture platforms, rising adoption of robotic liquid handling systems, growing use of scalable cell culture automation, expansion of closed-system cell processing, enhanced focus on reproducibility and sterility control.

The growing production of biopharmaceuticals is expected to drive the expansion of the automated cell cultures market in the coming years. Biopharmaceuticals are therapeutic drugs produced using biotechnology methods, including recombinant DNA technology and cell culture techniques. Their increasing demand is fueled by the ability to provide targeted and effective treatments with fewer side effects compared to conventional therapies. Automated cell culture systems improve efficiency and consistency in biopharmaceutical manufacturing by streamlining processes such as cell growth, monitoring, and harvesting. For example, in July 2025, according to Sartorius, a Germany-based global life science technology company, global biopharmaceutical sales increased by approximately 9 percent to reach USD 458 billion in 2024, up from the previous year, representing 41 percent of the total pharmaceutical market compared to 40 percent in 2023. Therefore, the rising production of biopharmaceuticals is driving the growth of the automated cell cultures market.

Key companies in the automated cell cultures market are focusing on technological innovations, such as integrated artificial intelligence (AI)-powered software, to enhance efficiency and gain a competitive edge. AI-integrated automated cell culture systems optimize experimental conditions by analyzing real-time data, improving cell growth, productivity, and workflow efficiency. For instance, in October 2023, Molecular Devices LLC, a US-based biotechnology company, launched the CellXpress.ai Automated Cell Culture System, designed to streamline complex cell culture workflows and enhance drug discovery processes through advanced automation and AI, allowing researchers to focus on higher-value tasks while improving reliability and efficiency.

In February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, partnered with Celltrio Inc. to deliver a fully automated cell culture system to biotherapeutics customers. By integrating Thermo Fisher's Momentum software with Celltrio's RoboCell platform, the collaboration aims to achieve fully automated cell line culturing. Celltrio Inc., a US-based company, specializes in providing automation solutions for biobanking and cell line development processes.

Major companies operating in the automated cell cultures market are Hitachi Ltd., Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group AG, Nikon healthcare, Sartorius AG, Beckman Coulter Inc., Celltrio Inc., Eppendorf AG, Tecan Trading AG, Shibuya Corp, Hamilton Company, Molecular Devices LLC, FORMULATRIX, Highres Biosolutions, Biotron Healthcare, Agilent Technologies, Miltenyi Biotec.

North America was the largest region in the automated cell cultures market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell cultures market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated cell cultures market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the automated cell cultures market by increasing costs of imported robotic systems, precision liquid handlers, sensors, software controllers, and laboratory automation components. Biopharmaceutical manufacturers and research institutes in North America and Europe are most affected due to reliance on imported automation equipment, while Asia-Pacific faces higher system integration costs. These tariffs are raising capital investment requirements and slowing laboratory upgrades. However, they are also driving local manufacturing of automation equipment, regional system integration capabilities, and innovation in modular and cost-efficient automated cell culture solutions.

The automated cell cultures market research report is one of a series of new reports that provides automated cell cultures market statistics, including automated cell cultures industry global market size, regional shares, competitors with a automated cell cultures market share, detailed automated cell cultures market segments, market trends and opportunities, and any further data you may need to thrive in the automated cell cultures industry. This automated cell cultures market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Automated cell cultures involve the use of robotic and automated systems to carry out cell culture tasks, including seeding, feeding, and harvesting cells. These systems minimize manual labor, improve reproducibility, and enhance the scalability of cell culture processes. Automation also helps maintain sterile conditions and ensures consistent experimental results.

The primary types of automated cell cultures are modular automation and whole-lab automation. Modular automation uses integrated pre- or post-analytical automation modules in laboratories to streamline workflows and improve efficiency. Equipment in these systems includes automated liquid handling systems, microplate readers, robotic platforms, automated storage and retrieval systems, and others. Applications span biopharmaceutical production, diagnostics, gene therapy, drug discovery and screening, toxicity testing, stem cell research, tissue engineering and regenerative medicine, personalized medicine, and more. These solutions are utilized by a range of end users, including pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, research institutes, and cell banks.

The automated cell cultures market consists of sales of automated bioreactors, cell culture platforms, and associated software for managing and analyzing cell growth and behavior. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.